Company Filing History:
1 out of 30 
1 out of 1 
1 out of 2 Years Active: 2024
Title: The Innovative Contributions of Shangjun Teng
Introduction: Shangjun Teng is a notable inventor based in Suzhou, China, recognized for his contributions to the field of organic chemistry. With a focus on alkynyl-containing compounds, Teng has developed a process that holds significant potential for pharmaceutical applications, particularly in cancer treatment.
Latest Patents: Teng's most prominent patent, titled "Process for preparing alkynyl-containing compound and intermediate thereof," outlines an innovative method for creating specific alkynyl-based compounds. This process not only enables the efficient preparation of these compounds but also includes formulations that could be utilized in developing effective pharmaceutical compositions aimed at combatting cancer.
Career Highlights: Throughout his career, Shangjun Teng has been associated with esteemed organizations such as Ascentage Pharma (Suzhou) Co., Ltd. and Ascentage Pharma Group Corporation Limited. His work in these companies has furthered advancements in oncological therapies and showcased his commitment to addressing critical health challenges through innovation.
Collaborations: In his professional journey, Teng has collaborated with various professionals, including Ming Guo and Jianfeng Wen. These collaborations have likely enriched his research endeavors and fostered an environment of shared knowledge and expertise within the field.
Conclusion: As an inventor, Shangjun Teng has made valuable strides in the area of alkynyl-containing compounds, emphasizing the importance of innovation in the pharmaceutical industry. His patent reflects not only a significant technical achievement but also a step forward in potential cancer therapies, highlighting the ongoing need for advancements in medical science.